Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa
about
Efflux-mediated drug resistance in bacteria: an updateThe crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmRNovobiocin binding to NalD induces the expression of the MexAB-OprM pump in Pseudomonas aeruginosaPentachlorophenol induction of the Pseudomonas aeruginosa mexAB-oprM efflux operon: involvement of repressors NalC and MexR and the antirepressor ArmRFmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expressionnalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosaProtein modulator of multidrug efflux gene expression in Pseudomonas aeruginosaPEG-protein interaction induced contraction of NalD chainsGenetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsOverexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in BrazilEfflux pump regulatory genes mutations in multidrug resistance Pseudomonas aeruginosa isolated from wound infections in Isfahan hospitals.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaInterplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolatesAntibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Efflux-mediated antimicrobial resistance.Characterization of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione resistance in pyomelanogenic Pseudomonas aeruginosa DKN343.Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.Bacterial outer membrane protein analysis by electrophoresis and microchip technology.Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Multicomponent drug efflux complexes: architecture and mechanism of assembly.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas aeruginosa.Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.Multidrug-Resistance Transporter AbcA Secretes Staphylococcus aureus Cytolytic Toxins.PA3225 Is a Transcriptional Repressor of Antibiotic Resistance Mechanisms in Pseudomonas aeruginosa.Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.Assembly of the MexAB-OprM multidrug pump of Pseudomonas aeruginosa: component interactions defined by the study of pump mutant suppressors.Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems.Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa.Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.Berberine inhibits the MexXY-OprM efflux pump to reverse imipenem resistance in a clinical carbapenem-resistant Pseudomonas aeruginosa isolate in a planktonic state.
P2860
Q24609407-208BD561-B73D-4C55-A118-0E704963BCE0Q27652278-86CC5ABB-F76C-4DD3-BC1E-EABBA9568E2DQ27703976-6D1C2381-4EC1-4D04-96B1-F6963B6AA124Q28492564-C6F72CE1-CDAA-4A61-A23F-24066BEA3FDAQ28492900-27516EC0-B098-4ACC-A356-FBECCE677AACQ28492924-E86A149D-9D58-4FE8-8A68-338B79B952FAQ28493010-B645337C-CA07-4B93-8A3B-DB2DAD209769Q28538613-F67FF56A-9EC8-4848-8D7C-FD1E6FC673FBQ29615301-E23A6F58-83BC-4CB8-96FB-3F0028709788Q30386653-8284A079-D529-4CC6-8511-FCEDE383AD9CQ33655586-5A011A07-89D5-4CFC-B7F3-9A29A919D36FQ33776291-34085656-F41D-4584-98B0-C89A4D06A645Q34647294-E2B31C1F-7145-4243-B7D1-751CF78153B9Q34648729-A7DDA5F9-5D02-4B7C-A6C0-8BE5E0AA2A34Q35007624-4048B99B-C15F-4BF5-BB83-ED6B97704286Q35482558-22CA140D-374D-417E-BA04-E9F9FFE72CE0Q36138147-E1D75440-F687-4EEF-90B4-AEB77FB6CB1FQ36389389-C61CF926-D3BC-47E5-99A2-A4FA5E5983CAQ36730030-1048E041-55FC-4F76-887F-171DFC2F3B53Q36731393-139736CB-144D-4722-BB9E-19C229CC427BQ37190771-2BD0F820-F335-445B-93AD-61AF41C26DCFQ37590328-B1F1176F-6BF6-4748-BA38-E7A2810E3DA2Q37643058-B58CF421-AD4E-4CC6-A302-16B775E55E6BQ37894832-6605781B-4576-4AA8-BF37-40818B368463Q38049220-42524F06-1B97-4507-BA90-C20B0669E8A8Q39097378-521417A9-1EC4-40A6-B4F0-79E1799D7AD0Q40325143-E82A082F-33BD-483D-BA9C-26418ABF1C36Q40334912-58AE78F3-F091-4055-AF1C-0EAA879A5F40Q41060499-C786AF96-1A47-4BAF-857A-1C3C23652109Q41115237-B8966CFE-E1DE-4B90-99C8-8D847A7F6A50Q41128937-CBFCD284-ECCD-4BDB-82B3-7DCAFDBF6351Q41183478-91E9E8E1-8061-48DC-9513-3C85C84F02EDQ41276707-771A52AF-1D10-473D-9BB5-B2A3B9E5ADB0Q41833848-49750624-C4EC-48F3-B37F-52D62E2F6DB3Q41908269-E4C13ED0-B57A-45FA-9F29-870ED4E97E3BQ42369851-A2CEEB4E-72C6-45C4-8B33-8840E99D7EC6Q43006550-87BF6974-D72A-4ADB-860E-095DB2D61486Q45897898-6A36923A-A604-4022-80DA-EE643EEB366AQ46271352-D2B24F11-94B7-48F0-8732-0632336C83DCQ49766082-7EC27DCC-13A9-46FC-B8E3-B3A48E828CC4
P2860
Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa
description
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/05/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/05/01)
@nl
наукова стаття, опублікована в травні 2005
@uk
مقالة علمية (نشرت في مايو 2005)
@ar
name
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@ast
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@en
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@nl
type
label
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@ast
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@en
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@nl
prefLabel
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@ast
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@en
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@nl
P2093
P2860
P1476
Mutations in PA3574 (nalD) lea ...... ates of Pseudomonas aeruginosa
@en
P2093
Didier Hocquet
Keith Poole
Mara L. Sobel
Patrick Plesiat
P2860
P304
P356
10.1128/AAC.49.5.1782-1786.2005
P407
P577
2005-05-01T00:00:00Z